Slides
Page 1
The world leader in serving scienceThe world leader in serving scienceMarc N. CasperChairman, President and Chief Executive OfficerJ.P. Morgan Healthcare ConferenceJanuary 13, 20261
Page 2
Safe Harbor / Non-GAAP Measures 2 Various remarks that we may make in the following presentation about the company’s future expectations, plans and prospects constitute forward-looking statements for purposes of the safe harbor provisions under The PrivateSecurities Litigation Reform Act of 1995, including statements about future revenue and financial results. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties, andare often identified by words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “may,” “will,” “should,” or similar expressions or words with similar meanings. Actual results may differ materially from thoseindicated by these forward-looking statements as a result of various important factors, including those discussed in our most recent reports on Form 10-K and Form 10-Q, under the caption “Risk Factors.” These filings are on file withthe Securities and Exchange Commission and available in the “Investors” section of our website under the heading “SEC Filings.” Forward-looking statements contained in this presentation are based on our current expectations andspeak only as of the date of this presentation. While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, in the event of new information, future developments orotherwise, except as requiredby law.During this presentation, we will be referring to certain financial measures not prepared in accordance with generally accepted accounting principles, or GAAP, including adjusted EPS, free cash flow, and organic revenue growth. Thenon-GAAP financial measures of Thermo Fisher’s results of operations and cash flows included in this presentation are not meant to be considered superior to or a substitute for Thermo Fisher’s results of operations prepared inaccordance with GAAP. Definitions of these non-GAAP financial measures and, for historical periods, a reconciliation of the non-GAAP financial measures to the most directly comparable GAAP measures is available in the appendixto this presentation. Thermo Fisher Scientific does not provide GAAP financial measures on a forward-looking basis because we are unable to predict with reasonable certainty and without unreasonable effort items such as the timingand amount of future restructuring actions and acquisition-related charges as well as gains or losses from sales of real estate and businesses, the early retirement of debt and the outcome of legal proceedings. The timing and amountof these items are uncertain and could be material to Thermo Fisher Scientific's results computed in accordance with GAAP. Certain amounts and percentages in this presentation are presented and calculated based on underlyingunroundedamounts.As a result,the sum of components may not equal correspondingtotals due to rounding.© 2025 Thermo Fisher Scientific Inc. All rights reserved. Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, PPD, Fisher Healthcare, Fisherbrand, Gibco, Ion Torrent, Olink, Astral,DynaDrive, Efficient-Pro, Excedion, Exent, Genexus, Krios, Oncomine, Orbitrap, Scios, and Vulcan are trademarks of Thermo Fisher Scientific and its subsidiaries. GenomeWeb is a trademark of GenomeWeb LLC. PharmaManufacturing is a trademark of Endeavor Business Media, LLC. OncLive is a trademark of Intellisphere, LLC. Manufacturing Digital is a trademark of BizClik Media Limited. Baird Maritime is a trademark of Baird Publications. BostonBusiness Journalis a trademark of AmericanCity BusinessJournalsInc..